Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Leukemia 33Breast Neoplasms 20Leukemia, Myeloid, Acute 15Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 13Head and Neck Neoplasms 13Congenital Abnormalities 12Squamous Cell Carcinoma of Head and Neck 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 9Kidney Neoplasms 9Central Nervous System Neoplasms 9Sarcoma 8Rectal Neoplasms 8Leukemia, Megakaryoblastic, Acute 8Colorectal Neoplasms 8Colonic Neoplasms 8Lymphoma, Follicular 7Leukemia, Myelomonocytic, Acute 7Leukemia, Monocytic, Acute 7Leukemia, Erythroblastic, Acute 7Gliosarcoma 7Glioblastoma 7Multiple Myeloma 6Melanoma 6Neuroblastoma 5Lymphoma, Large B-Cell, Diffuse 5Esophageal Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Wilms Tumor 4

Interventions

Cisplatin 30Pemetrexed 21Gemcitabine 11Radiotherapy 6Nivolumab 6Drug Therapy 6Cyclophosphamide 6Carboplatin 6durvalumab 4Vinorelbine 4Chemotherapy, Adjuvant 4tumor necrosis factor-alpha, CNGRC fusion protein, human 3sodium thiosulfate 3sargramostim 3Ipilimumab 3Doxorubicin 3raltitrexed 2pembrolizumab 2cediranib 2SS1(dsFv)PE38 2Radiotherapy, Intensity-Modulated 2Psychiatric Rehabilitation 2Photochemotherapy 2Neoadjuvant Therapy 2Methotrexate 2Interferon-alpha 2Imatinib Mesylate 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gefitinib 2Everolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mesothelioma, Malignant × Gene Expression Profiling × Clear all
NCT00541073 2011-05-17

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡